
Spanberger leads push to boost domestic prescription drug production
Pharmaceutical companies have regularly stopped producing key generic drugs. The reason: these medicines do not generate enough profit.

Pharmaceutical companies have regularly stopped producing key generic drugs. The reason: these medicines do not generate enough profit.

Gov. Glenn Youngkin made a show on Thursday with his signing of HB 884, sponsored by Del. Kathy Byron, R-Bedford, and SB 195, sponsored by Sen. Montgomery “Monty” Mason, D-Williamsburg, which will permit the creation of benefits consortiums for small businesses in Virginia.

Over the course of the pandemic, patients have benefited from increased access to telehealth services. However, for patients insured through Medicare, these flexibilities are temporary and tied to the COVID-19 Public Health Emergency declaration.

Energized for Change PAC, launched in 2019 by Northern Virginia Del. Eileen Filler-Corn to help Democrats gain the majority in the House of Delegates, is relaunching with an expanded scope to Turn Virginia Blue and help elect Democrats from the school board to Capitol Square.

The Virginia Department of Health has issued guidance in direct response to inquiries from parents and caregivers regarding the nationwide infant formula shortage.

Washington and Lee University held its 235th Commencement ceremony on Thursday.

As headlines focus on COVID-19 and, now, monkeypox, tuberculosis remains one of the great scourges of infectious disease around the world.

The growing concern of recent outbreaks of the rare monkeypox virus reported in the U.S. and abroad have health authorities monitoring transmission rates and keeping a close eye on the emerging issue.

COVID cases are up – way up, actually – with the latest wave. At this stage, we’re nowhere near where we were with the winter Omicron wave with either cases or hospitalizations.

Alzheimer’s costs our nation an astonishing $321 billion per year, including $206 billion in costs to Medicare and Medicaid. If we continue along this trajectory, Alzheimer’s is projected to claim the minds of 12.7 million seniors and nearly surpass $1 trillion in annual costs by 2050.
We don’t take press releases or official statements as the final word. Digging in to get the whole story takes time and resources.